Our advanced industrial-scale cell therapy manufacturing capabilities support the full life cycle of production services, covering preclinical, Phase I/II/III clinical trials, and commercial-scale production.
Applicable to preclinical and early clinical stages (Phases I/II), with proof of concept, process optimization, and validation
Designed for the production of cell therapy products during Phase III clinical trials and commercialization, featuring fully automated, closed-system production with minimal manual intervention and reduced inter-batch variation.
·Process Research
·Process Optimization and Validation
·Formulation and Process Development, Research, and Validation
·Development and Validation of Quality Analysis Methods
·Research and Establishment of Quality Attributes
·Accelerated Stability Study
·Storage Stability Study
·Transport Stability Study
·In-Use Stability Study
·Production of Seed Cell Bank for Clinical Trial Registration Batch
·Preparation of Drug Product Batches for Clinical Trial Registration
·Batch Quality Inspection
·Mechanism of Action Research
·Storage of Seed Cell Bank and Working Cell Bank
·Preclinical Toxicology Study Consulting
·Preclinical Pharmacodynamics Study Consulting
·CTD Document Preparation Consulting
·Process Optimization and Validation
·Formulation Optimization and Validation
·Comprehensive understanding of Quality attributes
·Optimization and Validation of Quality Analysis Methods
·Storage Stability Studies
·In-Use Stability Studies
·Seed Cell Bank Production
·Working Cell Bank Production
·Release Testing
·Clinical Trial Protocol Consulting
·Storage for Seed Cell Banks and Working Cell Banks
·Commercial Process Characterization, Process Validation and Continuous Process Validation
·Validation and Verification of Quality Assays
·Comparability Studies
·Storage Stability
·Production of Seed Cell Banks
·Production of Master Cell Banks
·Batch Release Testing
·eCTD Document Preparation Consulting
·Storage of Seed Cell Banks
·Storage of Master Cell Banks